<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Target 	</title>
	<atom:link href="https://www.newpharmaitaly.it/dragonfly-therapeutics-announces-new-research-collaboration-with-bristol-myers-squibb-to-develop-novel-therapeutic-candidates-for-multiple-sclerosis-and-neuro-inflammation-target/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/dragonfly-therapeutics-announces-new-research-collaboration-with-bristol-myers-squibb-to-develop-novel-therapeutic-candidates-for-multiple-sclerosis-and-neuro-inflammation-target/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Mon, 06 Jul 2020 11:01:10 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
